Related Experiment Video
Updated: May 31, 2026

Hydra, a Computer-Based Platform for Aiding Clinicians in Cardiovascular Analysis and Diagnosis
Published on: September 26, 2018
Artificial intelligence in cardiovascular care for internal medicine: from promising algorithms to useful clinical
Louis-Marie Desroche1, Antonin Trimaille2, Benoît Lequeux3
1Department of Cardiology, North Site, CHU de La Réunion, Allée des Topazes, Saint-Denis, La Réunion 97400, France; CIC-EC INSERM 1410, CHU de La Réunion, Saint-Denis, France.
Abstract:
Artificial intelligence is expanding rapidly in cardiovascular medicine, but its value in internal medicine depends less on raw model performance than on whether it improves triage, risk targeting, and coordination of care within real-world workflows. Rather than cataloguing applications, this review focuses on three use cases with near-term relevance in internal medicine: AI-augmented electrocardiography, risk prediction for targeted prevention, and AI-enabled clinical decision support, including selected applications of large language models. Across these domains, evaluation should extend beyond discrimination to calibration, positive predictive value at action thresholds, net benefit, alert burden, override rates, and downstream testing. Cardiovascular AI should not be judged as an autonomous decision-maker, but as a supervised component of care delivery. Its usefulness depends on predefined confirmation pathways, integration into existing information systems, actionable outputs, user training, and post-deployment monitoring for drift, safety, and equity. We propose a practical implementation lens - Train, Explain, Integrate, Accompany (TEIA) - to structure deployment in routine care, and summarize governance issues relevant to European practice, including intended use, interoperability, traceability, cybersecurity, and lifecycle oversight. The central question is not whether an AI tool can classify or predict, but whether its use in routine care supports better decisions with acceptable workload, safer pathways, and measurable clinical value.
Related Concept Videos
Cardiomyopathy V: Interprofessional Care
Issues And Trends In Healthcare Delivery System
Cost Containment
Payment for healthcare services has historically promoted adoption of costly and often unnecessary or inefficient...
Blood Studies for Cardiovascular System I: Cardiac Biomarkers
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...